UNSPSC 85613510: Occlusion of pancreatic duct with intraluminal device, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of pancreatic duct with intraluminal device, via natural or artificial opening endoscopic. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FLD8DZ

UNSPSC 85613510 Occlusion of pancreatic duct with intraluminal device, via natural or artificial opening endoscopic is a Commodity code that shows minimal alignment with recent state and local procurement activity. The recent opportunities tagged under this code involve independent medical evaluation services for disability pension benefit determinations, occupational health surveillance and screening examinations, surgical benefit carve-out program administration for municipal employee health plans, pharmacy benefit management services, emergency and specialty medical care for detained youth, and temporary health professional staffing coordination. None of these solicitations concern pancreatic duct procedures or intraluminal device deployment. The mismatch indicates that either the code has been applied incorrectly to these opportunities or the code itself sees little substantive procurement activity in the state and local space that matches its clinical definition.

The issuing bodies include county pension boards (Phoenix), state transportation agencies (Washington State Department of Transportation), municipal health systems (City of Long Beach, County of Santa Clara Health System), county detention systems (Harris County Juvenile Probation Department), county purchasing offices (Collier County Board of County Commissioners), and health consortia. Recent opportunities posted between July and September 2026 span Arizona, California, Florida, Texas, and Washington, with response deadlines clustered in early October 2026. Without traceable recent opportunities genuinely soliciting pancreatic duct occlusion procedures or related intraluminal device services through state and local procurement channels, the code does not support actionable market intelligence for business development purposes at this time.